Terms: = Breast cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Diagnosis
135 results:
1. cdh1 Genotype Exploration in Women With Hereditary Lobular breast cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract] [Full Text] [Related]
2. Malignant phyllodes tumor and invasive lobular breast carcinoma: Morpho-molecular characterization of an uncommon collision tumor and review of the literature.
Schaumann N; Bartels S; Kuehnle E; Kreipe H; Christgen M
Pathol Res Pract; 2024 Feb; 254():155100. PubMed ID: 38277744
[TBL] [Abstract] [Full Text] [Related]
3. Transversal Perspectives of Integrative Oncology Care in Gastric and Lobular breast cancer.
Giunta EF; Arrichiello G; Pappalardo A; Federico P; Petrillo A
Cancer Treat Res; 2023; 188():89-104. PubMed ID: 38175343
[TBL] [Abstract] [Full Text] [Related]
4. Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.
Blansky D; Ansari N; Gao L; Sokol ES; Sivakumar S; Huang RSP; Pelletier M; Levy M; Pavlick D; Danziger N; Ross JS; Lustberg M; Rozenblit M
Breast Cancer Res Treat; 2024 Feb; 204(1):181-185. PubMed ID: 37999916
[TBL] [Abstract] [Full Text] [Related]
5. Orthopaedic surgeons' ability to detect pathologic hip fractures: review of 1484 fractures reported to the Norwegian Hip Fracture Register.
Sund A; Dybvik E; Gjertsen JE
J Orthop Surg Res; 2023 Nov; 18(1):832. PubMed ID: 37925444
[TBL] [Abstract] [Full Text] [Related]
6. Nonlobular Invasive breast Carcinomas with Biallelic Pathogenic cdh1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Derakhshan F; Da Cruz Paula A; Selenica P; da Silva EM; Grabenstetter A; Jalali S; Gazzo AM; Dopeso H; Marra A; Brown DN; Ross DS; Mandelker D; Razavi P; Chandarlapaty S; Wen HY; Brogi E; Zhang H; Weigelt B; Pareja F; Reis-Filho JS
Mod Pathol; 2024 Feb; 37(2):100375. PubMed ID: 37925055
[TBL] [Abstract] [Full Text] [Related]
7. Germline cdh1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women.
Corso G; Comelli G; Veronesi P; Bianchi B; Petitto S; Polizzi A; Girardi A; Cioffi A; La Vecchia C; Bagnardi V; Magnoni F
J Cancer Res Clin Oncol; 2023 Nov; 149(17):16147-16155. PubMed ID: 37639007
[TBL] [Abstract] [Full Text] [Related]
8. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.
Vellichirammal NN; Tan YD; Xiao P; Eudy J; Shats O; Kelly D; Desler M; Cowan K; Guda C
Hum Genomics; 2023 Jul; 17(1):64. PubMed ID: 37454130
[TBL] [Abstract] [Full Text] [Related]
9. Prenatal diagnosis of hereditary diffuse gastric cancer: a case report.
Xiao J; Li H; Xue F; Luo Z; Pang Y
BMC Pregnancy Childbirth; 2023 Jul; 23(1):488. PubMed ID: 37393258
[TBL] [Abstract] [Full Text] [Related]
10. Effect of artificial intelligence-based computer-aided diagnosis on the screening outcomes of digital mammography: a matched cohort study.
Kim H; Choi JS; Kim K; Ko ES; Ko EY; Han BK
Eur Radiol; 2023 Oct; 33(10):7186-7198. PubMed ID: 37188881
[TBL] [Abstract] [Full Text] [Related]
11. Mutational signatures for breast cancer diagnosis using artificial intelligence.
Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
[TBL] [Abstract] [Full Text] [Related]
12. Fragmentation of Care and Its Association With Survival and Costs for Patients With breast cancer in Colombia.
Gamboa Ó; Buitrago G; Patiño AF; Agudelo NR; Espinel LS; Eslava-Schmalbach J; Guevara Ó; Caycedo R; Junca E; Bonilla C; Sánchez R
JCO Glob Oncol; 2023 May; 9():e2200393. PubMed ID: 37167575
[TBL] [Abstract] [Full Text] [Related]
13. Effectiveness and tasks of breast MRI surveillance for high-risk women with cancer susceptibility genes other than BRCA1/2: a single institution study.
Kikuchi M; Gomi N; Ueki A; Osako T; Terauchi T
Breast Cancer; 2023 Jul; 30(4):577-583. PubMed ID: 36897545
[TBL] [Abstract] [Full Text] [Related]
14. Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception.
Bychkovsky BL; Lo MT; Yussuf A; Horton C; Hemyari P; LaDuca H; Garber JE; Scheib R; Rana HQ
Breast Cancer Res Treat; 2023 Jul; 200(1):63-72. PubMed ID: 36856935
[TBL] [Abstract] [Full Text] [Related]
15. Metastatic breast cancer to the Spine: Incidence of Somatic Gene Alterations and Association of Targeted Therapies With Overall Survival.
Rabah NM; Jarmula J; Hamza O; Khan HA; Chakravarthy V; Habboub G; Wright JM; Steinmetz MP; Wright CH; Krishnaney AA
Neurosurgery; 2023 Jun; 92(6):1183-1191. PubMed ID: 36735514
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of phenomics and cfDNA in a large breast screening population: the breast Screening and Monitoring Study (BSMS).
Stebbing J; Takis PG; Sands CJ; Maslen L; Lewis MR; Gleason K; Page K; Guttery D; Fernandez-Garcia D; Primrose L; Shaw JA
Oncogene; 2023 Mar; 42(11):825-832. PubMed ID: 36693953
[TBL] [Abstract] [Full Text] [Related]
17. Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HCs, and TNBC versus non-TNBC.
Jin Y; Fan S; Jiang W; Zhang J; Yang L; Xiao J; An H; Ren L
Proteomics Clin Appl; 2023 May; 17(3):e2200042. PubMed ID: 36443927
[TBL] [Abstract] [Full Text] [Related]
18. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract] [Full Text] [Related]
19. Intraindividual Reliability of Opportunistic Computed Tomography-Assessed Adiposity and Skeletal Muscle Among breast cancer Patients.
Aduse-Poku L; Gopireddy DR; Hernandez M; Lall C; Divaker J; Falzarano SM; Masood S; Datta S; Zhang W; Jo A; Bian J; Cheng TD
JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36222575
[TBL] [Abstract] [Full Text] [Related]
20. Familial and hereditary gastric cancer, an overview.
Carneiro F
Best Pract Res Clin Gastroenterol; 2022; 58-59():101800. PubMed ID: 35988963
[TBL] [Abstract] [Full Text] [Related]
[Next]
